Consensus XP Inc. Buenos Aires S.E.

Stocks

XPD

ARBCOM4603Z1

Investment Banking & Brokerage Services

End-of-day quote Buenos Aires S.E. 02/10/2026			5-day change	1st Jan Change
5.650 ^USD	+5.21%		+6.40%	+32.01%

18/09	XP Insider Sold Shares Worth $2,413,865, According to a Recent SEC Filing	MT
15/09	Brazil derivatives exchange A5X raises $70 million in new funding round	RE

a971a40e5cc011.zW7AghdL3NAXitWO65aVFD0ld1nT4P8C8flqkFw6IEc.lSeLtn8YtYVxx5_PoM_lXW5oOAGnl40yxskN3G5xdTSjKLblb3ix5FnB7Q~56a18dc14349f8f8ebed370ce1611fae

Analysts' recommendations: XP Inc.

31/08	Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts PT to $22 From $19	MT
03/04	UBS Adjusts Price Target on XP to $28 From $25, Maintains Buy Rating	MT
21/01	Jefferies Initiates XP at Buy With $22 Price Target	MT
17/12	UBS Adjusts XP Price Target to $25 From $23, Maintains Buy Rating	MT
17/10/25	UBS Adjusts Price Target on XP to $23 From $24, Maintains Buy Rating	MT
24/06/25	XP Shares Drop After Downgrade From Itau BBA	MT
23/06/25	Itau BBA Downgrades XP to Market Perform From Outperform, Adjusts Price Target to $21 From $20	MT
10/06/25	UBS Adjusts XP Price Target to $24 From $17, Maintains Buy Rating	MT
04/06/25	Goldman Sachs Upgrades XP to Buy From Neutral, $23 Price Target	MT
14/05/25	XP Shares Rise After Morgan Stanley Upgrades to Overweight From Equalweight	MT
13/05/25	Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18	MT
08/04/25	UBS Adjusts Price Target on XP to $17 From $16, Keeps Buy Rating	MT
18/03/25	Itau BBA Initiates XP at Outperform With $20 Price Target	MT
25/01/25	XP Shares Rise After Upgrade From UBS	MT
25/01/25	UBS Upgrades XP to Buy From Neutral, Cuts Price Target to $16 From $19	MT
11/12/24	BofA Securities Downgrades XP to Neutral From Buy, Price Target is $16	MT
26/11/24	UBS Cuts Price Target on XP to $19 From $21, Maintains Neutral Rating	MT
11/07/24	UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30	MT
05/07/24	Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31	MT
06/06/24	Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating	MT
01/05/24	XP Shares Decline After Goldman Sachs Downgrade	MT
30/04/24	Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30	MT
23/04/24	Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31	MT
23/03/24	Citigroup Adjusts Price Target on XP to $29 From $28, Maintains Buy Rating	MT
12/12/23	UBS Adjusts XP Price Target to $30 From $31, Maintains Buy Rating	MT

More recommendations

Brokerage Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MORGAN STANLEY					+21.68%
	THE GOLDMAN SACHS GROUP, INC.					+23.73%
	CITIGROUP INC.					+20.16%
	CHARLES SCHWAB					+27.54%
	BANCO BTG PACTUAL S.A.					+2.42%
	CITIC SECURITIES COMPANY LIMITED					+46.95%
	EAST MONEY INFORMATION CO.,LTD.					+48.31%
	GUOTAI HAITONG SECURITIES CO., LTD.					+47.22%
	INTERACTIVE BROKERS GROUP, INC.					+19.37%
	Average					+28.60%
	Weighted average by Cap.					+24.67%